We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Radio Waves Heat Nanotubes Embedded in Tumors, Destroying Liver Cancer

By Biotechdaily staff writers
Posted on 20 Nov 2007
Cancer cells treated with carbon nanotubes can be destroyed by noninvasive radio waves that heat up the nanotubes while sparing untreated tissue.

A research team led by scientists from the University of Texas M.D. More...
Anderson Cancer Center (Houston, TX, USA) and Rice University (Houston, TX, USA) has shown in preclinical experiments that the technique completely destroyed liver cancer tumors in rabbits. Furthermore, there were no side effects noted. However, some healthy liver tissue within 2-5 mm of the tumors sustained heat damage due to nanotube leakage from the tumor.

"These are promising, even exciting, preclinical results in this liver cancer model,” stated senior author Steven Curley, M.D., professor in M.D. Anderson's department of surgical oncology. "Our next step is to look at ways to more precisely target the nanotubes so they attach to, and are taken up by, cancer cells while avoiding normal tissue.”

Targeting the nanotubes exclusively to cancer cells is the major challenge in advancing the therapy, according to Dr. Curley. Research is under way to bind the nanotubes to antibodies, peptides, or other agents that then can target molecules expressed on cancer cells. To complicate matters, most of these molecules also are expressed in normal tissue.

Dr. Curley estimates that a clinical trial is at least three to four years away. He conducted the research at M.D. Anderson in collaboration with nanotechnology specialists at Rice University and with Erie, Pennsylvania, entrepreneur John Kanzius of ThermMed LLC (Erie, PA, USA), who invented the experimental radio frequency generator used in the experiments.

In the liver cancer study, a solution of single-walled carbon nanotubes was injected directly into the tumors. Four treated rabbits were then exposed to two minutes of radio frequency treatment, resulting in thermal destruction of their tumors. Carbon nanotubes are hollow cylinders of pure carbon that measure approximately one billionth of a meter, or 1 nm, across. Control group tumors that were treated only by radio frequency exposure or only by nanotubes were undamaged.

In lab experiments, two lines of liver cancer cells and one pancreatic cancer cell line were destroyed after being incubated with nanotubes and exposed to the radio frequency field. "I'm humbled by the results of this research,” commented Mr. Kanzius. "I realize it's early in the race, but Dr. Curley and his team have moved on this carefully with utmost speed. I look forward to continuing to work with them and hopefully to watching the first person be treated with this procedure. The race isn't over but it needs to be taken to the finish line.”

Radio frequency energy fields penetrate deeply into tissue, so it would be possible to deliver heat anywhere in the body if targeted nanotubes or other nanoparticles can be delivered to cancerous cells, according to Dr. Curley. Without such a target, radio waves will pass harmlessly through the body.

An invasive technique known as radio frequency ablation is used to treat some malignant tumors, the investigators noted. It requires insertion of needle electrodes directly into the tumors. Incomplete tumor destruction occurs in 5-40% of cases, healthy tissue is damaged, and complications arise in 10% of patients who suffer such damage. Radio frequency ablation is limited to liver, kidney, breast, lung, and bone cancers.

The research was published online in November 2007 in advance of the December 2007 publication in the journal Cancer.


Related Links:
University of Texas M.D. Anderson Cancer Center
Rice University

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.